X-108137134-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000372232.8(ATG4A):c.511G>A(p.Val171Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000523 in 1,207,155 control chromosomes in the GnomAD database, including 1 homozygotes. There are 199 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00054 ( 0 hom., 17 hem., cov: 23)
Exomes 𝑓: 0.00052 ( 1 hom. 182 hem. )
Consequence
ATG4A
ENST00000372232.8 missense
ENST00000372232.8 missense
Scores
2
2
13
Clinical Significance
Conservation
PhyloP100: 9.02
Genes affected
ATG4A (HGNC:16489): (autophagy related 4A cysteine peptidase) Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly. Autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels of autophagy have been described in some malignant tumors, and a role for autophagy in controlling the unregulated cell growth linked to cancer has been proposed. This gene encodes a member of the autophagin protein family. The encoded protein is also designated as a member of the C-54 family of cysteine proteases. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10917336).
BS2
High Hemizygotes in GnomAd4 at 17 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG4A | NM_052936.5 | c.511G>A | p.Val171Ile | missense_variant | 7/13 | ENST00000372232.8 | NP_443168.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATG4A | ENST00000372232.8 | c.511G>A | p.Val171Ile | missense_variant | 7/13 | 1 | NM_052936.5 | ENSP00000361306 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000540 AC: 61AN: 112935Hom.: 0 Cov.: 23 AF XY: 0.000485 AC XY: 17AN XY: 35075
GnomAD3 genomes
AF:
AC:
61
AN:
112935
Hom.:
Cov.:
23
AF XY:
AC XY:
17
AN XY:
35075
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000343 AC: 62AN: 180941Hom.: 0 AF XY: 0.000244 AC XY: 16AN XY: 65511
GnomAD3 exomes
AF:
AC:
62
AN:
180941
Hom.:
AF XY:
AC XY:
16
AN XY:
65511
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000521 AC: 570AN: 1094167Hom.: 1 Cov.: 28 AF XY: 0.000506 AC XY: 182AN XY: 359817
GnomAD4 exome
AF:
AC:
570
AN:
1094167
Hom.:
Cov.:
28
AF XY:
AC XY:
182
AN XY:
359817
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000540 AC: 61AN: 112988Hom.: 0 Cov.: 23 AF XY: 0.000484 AC XY: 17AN XY: 35138
GnomAD4 genome
AF:
AC:
61
AN:
112988
Hom.:
Cov.:
23
AF XY:
AC XY:
17
AN XY:
35138
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.511G>A (p.V171I) alteration is located in exon 7 (coding exon 7) of the ATG4A gene. This alteration results from a G to A substitution at nucleotide position 511, causing the valine (V) at amino acid position 171 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
D;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
P;P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at